Litcius/Paper detail

Alisertib inhibits migration and invasion of EGFR-TKI resistant cells by partially reversing the epithelial-mesenchymal transition

Cheng‐Yi Wang, Meng-Hsuan Lee, Yu-Rung Kao, Shih-Hsin Hsiao, Shiao‐Ya Hong, Cheng‐Wen Wu

2021Biochimica et Biophysica Acta (BBA) - Molecular Cell Research18 citationsDOI

Topics & Concepts

ReversingEpithelial–mesenchymal transitionMesenchymal stem cellCancer researchTransition (genetics)ChemistryCell biologyMedicineBiologyMaterials scienceBiochemistryComposite materialGeneLung Cancer Treatments and MutationsCytokine Signaling Pathways and InteractionsPI3K/AKT/mTOR signaling in cancer
Alisertib inhibits migration and invasion of EGFR-TKI resistant cells by partially reversing the epithelial-mesenchymal transition | Litcius